Literature DB >> 9370925

Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance.

M Kjerrulf1, D Grdic, L Ekman, K Schön, M Vajdy, N Y Lycke.   

Abstract

Interferon-gamma (IFN-gamma) receptor knock-out (IFN-gamma R -/-) mice were used to analyse the role of IFN-gamma in mucosal immune responses following oral immunization. We found that the IFN-gamma R -/- mice demonstrated 50% reduced spot-forming cell (SFC) responses in the gut lamina propria and spleen after oral immunization with keyhold limpet haemocyanin (KLH) plus cholera toxin (CT) adjuvant. The IFN-gamma R -/- mice exhibited 10-fold reduced total serum KLH-specific antibody levels compared with wild-type mice after oral immunization, while after intravenous immunization, no such difference was seen, suggesting a selective impairment of mucosal immune responses. Moreover, oral immunizations resulted in impaired interleukin-4 (IL-4), IL-10 and IFN-gamma production by spleen T cells from IFN-gamma R -/- mice, indicating that no reciprocal up-regulation of Th2-activities had occurred despite the lack of IFN-gamma R function. No reduction in Th1 or Th2 cytokines was observed following systemic immunizations. Despite potentially strong modulating effects of IFN-gamma on epithelial cell IgA transcytosis and electrolyte barrier functions, CT-immunized IFN-gamma R -/- mice demonstrated unaltered protection against CT in ligated intestinal loops together with normal anti-CT IgA and total IgA levels in gut lavage. Oral feeding with KLH followed by parenteral immunization resulted in strongly suppressed SFC numbers and reduced cell-mediated immunity in both wild-type and IFN-gamma R -/- mice. CT-adjuvant abrogated induction of oral tolerance in both IFN-gamma R -/- and wild-type mice. Collectively, our data argue that the two major response patterns induced by oral administration of protein antigen, i.e. active IgA immunity and oral tolerance, are differently regulated. Thus, IFN-gamma R -/- mice have impaired mucosal immune responses while induction of oral tolerance appears to be unaffected by the lack of IFN-gamma functions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9370925      PMCID: PMC1363982          DOI: 10.1046/j.1365-2567.1997.00312.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  44 in total

1.  Gamma-interferon-mediated down-regulation of electrolyte secretion by intestinal epithelial cells: a local immune mechanism?

Authors:  J Holmgren; J Fryklund; H Larsson
Journal:  Scand J Immunol       Date:  1989-10       Impact factor: 3.487

2.  Priming of systemic and local delayed-type hypersensitivity responses by feeding low doses of ovalbumin to mice.

Authors:  A G Lamont; A M Mowat; D M Parrott
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

3.  Up-regulation of the expression of secretory component and HLA molecules in a human colonic cell line by tumour necrosis factor-alpha and gamma interferon.

Authors:  D Kvale; P Brandtzaeg; D Løvhaug
Journal:  Scand J Immunol       Date:  1988-09       Impact factor: 3.487

4.  Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.

Authors:  N Lycke; J Holmgren
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

5.  Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins.

Authors:  L M Sollid; D Kvale; P Brandtzaeg; G Markussen; E Thorsby
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

6.  Orally inducible immune unresponsiveness is abrogated by IFN-gamma treatment.

Authors:  Z Y Zhang; J G Michael
Journal:  J Immunol       Date:  1990-06-01       Impact factor: 5.422

7.  Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory.

Authors:  M Quiding; I Nordström; A Kilander; G Andersson; L A Hanson; J Holmgren; C Czerkinsky
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

8.  A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions.

Authors:  C O Elson; W Ealding; J Lefkowitz
Journal:  J Immunol Methods       Date:  1984-02-24       Impact factor: 2.303

9.  Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers.

Authors:  J L Madara; J Stafford
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

10.  Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures.

Authors:  D A Lebman; R L Coffman
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  16 in total

1.  Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cells.

Authors:  R M Hershberg; D H Cho; A Youakim; M B Bradley; J S Lee; P E Framson; G T Nepom
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

2.  Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71.

Authors:  Chun-Che Liao; An-Ting Liou; Ya-Shu Chang; Szu-Yao Wu; Chih-Shin Chang; Chien-Kuo Lee; John T Kung; Pang-Hsien Tu; Ya-Yen Yu; Chi-Yung Lin; Jen-Shiou Lin; Chiaho Shih
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

3.  A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection.

Authors:  Wei Xin Khong; Benedict Yan; Huimin Yeo; Eng Lee Tan; Jia Jun Lee; Jowin K W Ng; Vincent T Chow; Sylvie Alonso
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

4.  Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects.

Authors:  Subhra Chakraborty; Clayton Harro; Barbara DeNearing; Jay Bream; Nicole Bauers; Len Dally; Jorge Flores; Lillian Van de Verg; David A Sack; Richard Walker
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

5.  Induction of the trypanosome lymphocyte-triggering factor (TLTF) and neutralizing antibodies to the TLTF in experimental african trypanosomiasis.

Authors:  M Hamadien; N Lycke; M Bakhiet
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

6.  The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome.

Authors:  N Van Damme; F De Keyser; P Demetter; D Baeten; H Mielants; G Verbruggen; C Cuvelier; E M Veys; M De Vos
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

7.  Diversion of intestinal flow decreases the numbers of interleukin 4 secreting and interferon gamma secreting T lymphocytes in small bowel mucosa.

Authors:  A Schmit; A Van Gossum; M Carol; J J Houben; F Mascart
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

Review 8.  Mechanism of oral tolerance induction to therapeutic proteins.

Authors:  Xiaomei Wang; Alexandra Sherman; Gongxian Liao; Kam W Leong; Henry Daniell; Cox Terhorst; Roland W Herzog
Journal:  Adv Drug Deliv Rev       Date:  2012-11-02       Impact factor: 15.470

9.  Oral tolerance is inefficient in neonatal mice due to a physiological vitamin A deficiency.

Authors:  M Turfkruyer; A Rekima; P Macchiaverni; L Le Bourhis; V Muncan; G R van den Brink; M K Tulic; V Verhasselt
Journal:  Mucosal Immunol       Date:  2015-11-04       Impact factor: 7.313

10.  Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development.

Authors:  Kristina Eriksson; Margareta Fredriksson; Inger Nordström; Jan Holmgren
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.